Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone and Lithium for Suicidality in MDD
NCT01134731Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- May 2010
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of paliperidone in major depressive disorder (MDD) and suicidal ideation (3 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Beck Scale for Suicidal Ideation at 12 weeks. Started May 2010; status: completed.
02
Drugs
paliperidone
03
Conditions
major depressive disorder (MDD)suicidal ideation
Beyond the preview
Go deeper on NCT01134731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01134731.